Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (Text with EEA relevance)
Print Options
PrintThe Whole
Regulation
PrintThe Whole
Chapter
PrintThis
Article
only
Changes over time for: Article 95A
Timeline of Changes
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Status:
Point in time view as at 31/12/2020.
Changes to legislation:
There are currently no known outstanding effects for the Regulation (EU) No 528/2012 of the European Parliament and of the Council, Article 95A.
Changes to Legislation
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
[Article 95AU.K. Transitional measures for simplified notification procedure
1.Where, before IP completion day, a product was authorised in a country which was a Member State of the EU other than the United Kingdom in accordance with Article 26 of Regulation (EU) No 528/2012, and was placed on the market in the United Kingdom in accordance with Article 27 of Regulation (EU) No 528/2012—
(a)it is to be treated as if it were authorised by the competent authority under Article 26 of this Regulation, and
(b)the competent authority must grant an authorisation under Article 26 of this Regulation.
2.The authorisation must be cancelled and Article 52 of this Regulation will apply where—
(a)the authorisation holder is not established in the United Kingdom within 12 months from IP completion day, or
(b)the authorisation holder does not supply the competent authority with relevant scientific and authorisation data by whichever is the earlier of the following—
(i)the date of any application for renewal or the date of any application for amendment of the authorisation under Article 50 of this Regulation, or
(ii)within 60 days of any request made by the competent authority to the authorisation holder.]
Back to top